TY - JOUR
T1 - Lysosomal storage disorders and Parkinson's disease
T2 - Gaucher disease and beyond
AU - Shachar, Tamar
AU - Bianco, Christophe Lo
AU - Recchia, Alessandra
AU - Wiessner, Christoph
AU - Raas-Rothschild, Annick
AU - Futerman, Anthony H.
PY - 2011/8/1
Y1 - 2011/8/1
N2 - Parkinson's disease is associated with mutations in the glucocerebrosidase gene, which result in the enzyme deficiency causing Gaucher disease, the most common lysosomal storage disorder. We have performed an exhaustive literature search and found that additional lysosomal storage disorders might be associated with Parkinson's disease, based on case reports, the appearance of pathological features such as α-synuclein deposits in the brain, and substantia nigra pathology. Our findings suggest that the search for biochemical and cellular pathways that link Parkinson's disease with lysosomal storage disorders should not be limited exclusively to changes that occur in Gaucher disease, such as changes in glucocerebrosidase activity or in glucosylceramide levels, but rather include changes that might be common to a wide variety of lysosomal storage disorders. Moreover, we propose that additional genetic, epidemiological, and clinical studies should be performed to check the precise incidence of mutations in genes encoding lysosomal proteins in patients displaying Parkinson's symptoms.
AB - Parkinson's disease is associated with mutations in the glucocerebrosidase gene, which result in the enzyme deficiency causing Gaucher disease, the most common lysosomal storage disorder. We have performed an exhaustive literature search and found that additional lysosomal storage disorders might be associated with Parkinson's disease, based on case reports, the appearance of pathological features such as α-synuclein deposits in the brain, and substantia nigra pathology. Our findings suggest that the search for biochemical and cellular pathways that link Parkinson's disease with lysosomal storage disorders should not be limited exclusively to changes that occur in Gaucher disease, such as changes in glucocerebrosidase activity or in glucosylceramide levels, but rather include changes that might be common to a wide variety of lysosomal storage disorders. Moreover, we propose that additional genetic, epidemiological, and clinical studies should be performed to check the precise incidence of mutations in genes encoding lysosomal proteins in patients displaying Parkinson's symptoms.
KW - Gaucher disease
KW - Glucosylceramide
KW - Lipid
KW - Lysosomal storage disorders
KW - Neurodegenerative diseases
KW - Parkinson's disease
KW - Parkinsonism
KW - Synuclein
UR - http://www.scopus.com/inward/record.url?scp=79960360692&partnerID=8YFLogxK
U2 - 10.1002/mds.23774
DO - 10.1002/mds.23774
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 21618611
AN - SCOPUS:79960360692
SN - 0885-3185
VL - 26
SP - 1593
EP - 1604
JO - Movement Disorders
JF - Movement Disorders
IS - 9
ER -